ORMDL3 EXPRESSION IN ASM REGULATES HYPERTROPHY, HYPERPLASIA VIA TPM1 AND TPM4, AND CONTRACTILITY



Advances in nanotechnology for the treatment of GBM

Glioblastoma (GBM), a highly malignant glioma of the central nervous system, is the most dread and common brain tumor with a high rate of therapeutic resistance and recurrence.Currently, the clinical treatment Sun Hat methods are surgery, radiotherapy, and chemotherapy.However, owning to the highly invasive nature of GBM, it is difficult to complet

read more